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Summary 
Focal adhesion kinase (pp125 FAK) is localized to focal adhesions and tyrosine phosphorylated by 
the  engagement of 61  integrins.  However,  it is unclear  how pp125 rAK is linked  to  integrin 
molecules. We demonstrate that pp125 FAK is directly associated with paxillin, a 68-kD cytosk- 
eleton protein. The COOH-terminal domain ofppl25 FAK spanning FAK residues 919-1042 is 
sufficient for paxillin binding and has vinculin-homologous amino acids, which are essential for 
paxillin binding. Microinjection and subsequent imrnunohistochemical analysis reveal that glu- 
tathione S-transferase-FAK fusion proteins, which bind to paxillin, localize to focal adhesions, 
whereas fusion  proteins with no  paxillin-binding activity do  not localize to  focal adhesions. 
These findings strongly suggest that pp125 FAK is localized to focal adhesions by the direct asso- 
ciation with paxillin. 
th•at 
1 integrins, also known as very late activation antigens, 
constitute  a  subfamily of integrin  adhesion  receptors 
is comprised by at least nine o~ subunits sharing a com- 
mon [31 subunit  (1, 2).  [31 integrins function as cell-surface 
receptors for extracellular matrix protein  (ECM) 1 and also 
mediate cell-to-cell interaction (1, 2). The marked changes 
in morphology and behavior that occur when cells interact 
with ECM through their integrins suggest that these recep- 
tors can function as transducers of extracellular signals  into 
cells  (2, 3). Several laboratories including ours have shown 
that  [31  integrins  synergize with  the  TCR-CD3  pathway 
to promote T  cell proliferation (4-6).  [31 integrins are also 
reported  to  be  involved  in  T  or  B  cell  differentiation 
through  interaction with fibronectin expressed by stromal 
cells  in thymus or bone marrow,  respectively (7,  8).  Fur- 
thermore, it was also reported that integrin-ECM binding 
induced increases of cytoplasmic Ca  2+ and cytoplasmic pH 
(9,  10).  These facts strongly support the notion that the in- 
teraction between [31  integrins and ECM transmits signals 
into the interior of cells. 
In an effort to clarify mechanisms ofT cell costinmlatory 
signals mediated by [31 integrins, we found that tyrosine ki- 
nase  activation might be a  key event in  this  process. We 
showed that tyrosine phosphorylation of 105-130-kD pro- 
IAbbreviations used in  this paper: ECL, enhanced chemiluminescence; 
ECM, extracellular  matrix protein; FAT, focal adhesion targeting; FN, fi- 
bronectin; FRNK, FAK-related nonkinase; GST, glutathione S-trans- 
ferase; PBS-T, PBS containing 0.1% Tween 20; PBS1, paxillin-binding 
subdomain 1; PBS2, paxillin-binding subdomain 2; pp  125 yAK, focal adhe- 
sion kinase; PTK, protein tyrosine kinase. 
teins was induced by the ligation of [31 or ci4 integrin sub- 
units using either fibronectin (FN)  or mAbs in human pe- 
ripheral T  cells  and H9,  a T  lymphoblastoid cell line  (11, 
12).  Several independent studies also showed that tyrosine 
phosphorylation of proteins in the range of 120-130 kD is 
induced  by  the  engagement  of [31  integrins  in  different 
types of cells  including  mouse fibroblasts and human  epi- 
dermal  cancer  cell  line  (13,  14).  One  of these  tyrosine- 
phosphorylated proteins was identified  as  the  Wrosine  ki- 
nase, focal adhesion kinase (pp125 FAK) (15,  16). 
pp125 F^K was  first  identified  as  a  putative substrate  for 
the  oncogenic retrovirus gene product pp60  .....  (17).  De- 
duced amino acid sequence revealed FAK to be a novel cy- 
toplasmic tyrosine kinase  having relatively low homology 
to other known kinases and lacking SH2 and SH3 domains 
(15).  pp125 FAK is localized to focal adhesions  (15),  which 
are the sites where cells adhere to the substrata via integrin- 
ECM  binding.  Subsequently,  pp125 F^K was  shown  to  be 
tyrosine phosphorylated by the ligation of [31 integrins (18, 
19).  Since integrins lack an intrinsic protein tyrosine kinase 
(PTK) activity, these findings about pp125 F^K strongly sug- 
gest important roles of ppl25 F^K in the [31 integrin-medi- 
ated signaling.  However, the nature of the interaction be- 
tween [31 integrins and pp125 F^K remains unclear. 
FAK-related  nonkinase  (FRNK),  an  autonomously  ex- 
pressed COOH-terminal non-catalytic domain ofppl25  r^K, 
was reported to be localized to focal adhesions  (20),  sug- 
gesting that pp125 FAK COOH-terminal region plays an im- 
portant  role  in  the  focal  adhesion  targeting  (FAT)  of 
pp125 yAK. Moreover,  Hildebrand  et  al.  reported  that  the 
FAT domain ofppl25  FAK, which is responsible for pp125 F^K 
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terminal region  of pp125 F^K  (21).  pp125  F^K  and  FRNK 
were reported to be coprecipitated with paxillin, a 68-kD 
cytoskeletal protein that is localized to focal adhesions (22, 
23). However, to date, the precise association ofppl25  F^K 
via its  FAT domain with  other  molecules and  the  func- 
tional consequence of such association remain unresolved. 
In this study, we  demonstrate that pp125  F^K is directly 
associated  with  paxillin, yet  tyrosine  phosphorylations of 
pp125  FAK and paxillin are not necessary for this association. 
The  paxiUin-binding domain  of pp125  F^K  that  we  have 
identified is homologous to the paxillin-binding  domain of 
vinculin (24). Mutations in the conserved amino acid resi- 
dues between pp125  F^K and vinculin result in the  loss  of 
paxillin-binding  activity. The relevance between paxillin- 
binding activity and FAT ofppl25  FAre is presented by using 
various deletion and substitution mutants ofppl25  ~^K. 
Materials and Methods 
Cell Culture and Stimulation.  A  human T  lymphoblastoid  cell 
line, HPB-ALL, a human breast cancer cell line, T-47D, and 3T3 
Swiss albino cells were  obtained from American Type Culture 
Collection (Rockville, MD) and cultured in 7.5% CO2 incubator 
supplemented with 10% newborn calf serum in RPMI 1640, 10% 
FCS  in RPMI  1640,  and 5% FCS in DMEM.  For stimulation, 
HPB-ALL cells were washed three times with Iscove's serum-free 
medium (Sigma Chemical Co., St. Louis, MO), incubated for 30 
rnin in CO2 incubator in plates coated  with 5 btg/ml human fi- 
bronectin (G1BCO BRL, Gaithersburg,  MD) or antibodies,  and 
blocked with 1% BSA (Fraction  V; Sigma Chemical Co.). After 
incubation, cells attached  to substrata were lysed on plates in 1% 
NP-40 lysis buffer (50 mM Tris-HC1,  pH 8.0,  140 mM NaC1, 5 
mM  EDTA,  10  mM  NaF,  2  mM  sodium pyrophosphate,  1% 
NP-40, 20 mM iodoacetarnide,  0.2 trypsin inhibitor U/nil apro- 
tinin, 1 p~g/ml pepstatin  A,  l  rnM PMSF,  and 0.4 mM sodium 
orthovanadate).  Cells not attached  to substrata were collected  by 
centrifugation and lysed in the same lysis buffer used for on-plate 
lysis. T-47D cells were washed  twice with PBS and lysed in 1% 
NP-40 lysis buffer. 
cDNA Cloning of  Human FAK Gene and Construction of Glutathione 
S-Transferase (GST)-FAK Fusion Protein Expression Vectors.  Hu- 
man FAK cDNA was obtained by screening kgt 10 human fetal 
brain cDNA library (CLONTECH, Palo Alto, CA) with 32p-la- 
beled chick  FAK cDNA fragments, which were kindly provided 
by J.  T. Parsons (University of Virginia, Charlottesville,  VA).  12 
cDNA clones of various lengths  were isolated.  Full-length FAK 
cDNA reconstructed from three cDNA clones  carried  4,347  bp 
in total  and an open-reading frame  coding 1,082  amino acids. 
This  open-reading ti-ame carried  30  extra  amino acids  in  the 
NH~_-terminal region in addition to  reported hmnan or mouse 
FAK cDNAs (18, 25). In this article, the number of FAK amino 
acid  indicated the  number of 1,052  amino acids open-reading 
frame for the convenience of readers to compare with other pub- 
lications. 
Plasrnids that coded GST fusion proteins were constructed by 
the insertion of human FAK cDNA fragments into pGEX-2T or 
pGEX-3X (Pharrnacia Biotech Inc., Piscataway, NJ). Insert DNA 
fragnnents for deletion mutants were developed by appropriate  re- 
striction enzymes or by PCR with specific primers  flanked with 
BamHl site (5' primer)  and with EcolLl site (3' primer).  Substi- 
tution mutants were generated by PCR to substitute  one amino 
acid residue of the GST-FAK fusion protein containing residues 
896-1052 (26). JM 105 cells carrying plasmids were inoculated in 
the presence of 0.1  mM isopropyl-[3-D-thiogalactopyranoside  to 
express GST-FAK fusion proteins.  Cells were collected by centri- 
fuge,  resuspended  in NETN buffer (20 mM Tris-HCl, pH 8.0, 
100 mM NaC1, l  mM EDTA, 0.5% NP-40), sonicated,  and in- 
cubated with BSA-blocked glutathione-Sepharose 4B (Pharmacia 
Biotech. Inc.). After incubation, beads were washed with NETN 
buffer and subjected to precipitation. 
lmmunoprecipitation and Immunoblotting.  To establish 10G2 mAb, 
the GST-FAK fusion protein containing FAK residues 706-1052 
was used as the antigen and the source for screening hybridoma. 
Culture supernatant or ascites of 10G2  mAb were  purified by 
protein G (Pierce, Rockford, IL). 
For immunoprecipitation, cells were lysed in 1% NP-40 lysis 
buffer.  Cellular lysates were incubated overnight with rotation in 
the cold room with glutathione-Sepharose conjugated with GST- 
FAK  fusion proteins  or  antiphosphotyrosine mAb-conjugated 
beads  (4G10,  Upstate  Biotechnology,  Inc.,  Lake Placid,  NY). 
Otherwise, cellular lysates were incubated overnight with first an- 
tibodies  and  then  with  goat  anti-mouse  IgG  Ab-conjugated 
beads  (Sigma Chemical Co.)  for 4  h  with rotation in the  cold 
room. Beads were washed  with  1% NP-40 washing buffer  (1% 
NP-40, 50 mM Tris-HC1,  pH 8.0,  140 mM NaC1, and 2.5 mM 
EDTA) five times. Washed beads were boiled 5 rnin at 100~  in 
the presence  of 2% SDS and 0.1  M  dithiothreitol, and superna- 
tants  of boiled samples  were  loaded  onto  SDS-polyacrylamide 
gels.  For the  second imrnunoprecipitation, washed  beads  were 
boiled 5 rain at 100~  in the presence of 1% SDS, and the super- 
natants were precipitated  with antibodies in the 1% NP-40 wash- 
ing buffer containing 0.1% SDS. 
For immunoblotting,  samples were subjected  to electrophore- 
sis  in  7.5%  polyacrylamide  gels containing 0.1%  SDS, elec- 
trotransferred  onto  nitrocellulose membranes  (BioBlot;  Costar 
Corp., Cambridge, MA), and blocked for 2 h with PBS contain- 
ing 3%  BSA  at  room temperature.  After  blocking, membranes 
were incubated with 0.1 I.zg/ml first antibodies in PBS containing 
I% BSA,  washed  in PBS  containing 0.l% Tween 20  (PBS-T), 
incubated with  horseradish  peroxidase-conjugated sheep  anti- 
mouse IgG Ab (I 0,000 times dilution) in PBS-T, washed in PBS- 
T, and analyzed by the enhanced chemiluminescence (ECL) sys- 
tem  (Amersharn  Corp.,  Arlington Heights,  1L). In the  case of 
12SI-labeled antibodies,  membranes were incubated overnight in 
the cold room with 125I-labeled  antiphosphotyrosine mAb (4G10, 
kindly provided by Brian Druker, Dana-Farber Cancer Institute, 
Boston, MA)  or 10G2 mAb in PBS-T, were washed  in PBS-T, 
and were subjected to autoradiography.  The method used in ~251- 
labeling of antibodies was described  elsewhere  (1 l).  Membranes 
were reprobed with other antibodies after reblocking. For overlay 
assay, GST-FAK fusion  protein  containing FAK  residues  706- 
1052 was IzsI labeled by the same method and used instead of ra- 
diolabeled antibodies. 
Microinjection and 1mmunofluorescence.  GST-FAK  fusion  pro- 
teins were washed  on beads with PBS, eluted from beads by the 
elution solution (20 mM glutathione, 50 mM Tris-HCl, final pH 
8.0),  and dialyzed with DMEM.  Microinjection was perfonued 
based  on  the  syringe-loading method  described  by Clarke  and 
McNeil (27). Swiss 3T3 cells were trypsinized,  collected by cen- 
trifugation,  resuspended in 200-300 I~1 DMEM containing  2 rag/ 
ml  GST-FAK fusion  proteins and 0.5%  wt/vol  Pluronic F-68 
(Sigma Chemical Co.).  Cells  were  passed through hypodermic 
needles  (30G; Hamilton Co., Reno, NV) 30 times, collected  by 
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FCS--supplemented  DMEM.  For  immunostaining,  cells  were 
fixed and immersed with PBS containing 3.7% formaldehyde and 
PBS containing 0.2% Triton X-100.  Cells were then  incubated 
with first antibodies in PBS (antipaxillin  mAb, 1:50, or anti-GST 
mAb,  1:100),  washed  with  PBS,  incubated  with  FITC-conju- 
gated goat anti-mouse IgG Ab (Tago, Inc., Burlingame,  CA) in 
PBS (1:50),  washed, and subjected to analysis with fluoromicros- 
copy (Axioskop; Carl Zeiss,  Inc., Thornwood, NY). 
Results 
Identification  of a  Tyrosine-phosphorylated  70-kD pp125  FaK- 
associated Protein as Paxillin.  It is now established that one of 
the  major  substrates  for  integrin-mediated  tyrosine  phos- 
phorylation is pp125 F~,  a  125-kD  cytoplasmic PTK.  Fur- 
thermore,  our recent studies indicated  that the solid-phase 
cross-linking  of 131 integrin  by antibodies  or its ligand  FN 
stimulated  tyrosine  phosphorylation  of several  additional 
proteins,  such  as  140,  110-130,  70,  55-60,  and  45  kD  in 
peripheral  T  cells (27a) and in a T  lymphoblastoid cell line, 
HPB-ALL (data not shown).  To determine the relationship 
between  pp125 FAK and these  other proteins,  we attempted 
to define pp125FAK-associated molecules.  For this purpose, 
lysates of HPB-ALL  cells with  or without  FN  stimulation 
were precipitated  with the anti-FAK mAb  (10G2)  or with 
the  GST fusion protein  containing  pp125 rAK COOH-ter- 
minal region residues 706-1052,  and were analyzed by im- 
munoblotting with antiphosphotyrosine  mAb. As shown in 
Fig.  1, tyrosine-phosphorylated pp125 F~K was well precipi- 
tated  with  10G2  mAb,  whereas  no  additional  tyrosine- 
phosphorylated  proteins  were  detected  by  precipitation 
with  10G2  mAb  (lane  6).  However,  a  70-kD  protein, 
which  was  precipitated  by  the  GST-FAK  fusion  protein 
from  the  lysate  of  FN-stimulated  HPB-ALL  cells,  was 
clearly  detected  by  immunoblotting  with  antiphosphoty- 
rosine mAb (Fig.  1 A, lane  8). This 70-kD protein was not 
detected  by  antiphosphotyrosine  mAb  blotting  in  the  ab- 
sence  of FN  stimulation  (Fig.  1  A,  lane  4).  These  results 
suggest the following:  (a) a 70-kD protein is tyrosine phos- 
phorylated  by  FN  stimulation  in  HPB-ALL  cells;  (b)  this 
70-kD  protein  (pp70)  binds to FAK protein,  although  it is 
not  clear whether  tyrosine phosphorylation  of this protein 
is required  for binding to pp125 F~.  Tyrosine phosphoryla- 
tion  in  the  binding  site  of pp125 F~  is  not  necessary  for 
pp70  binding,  because  the  GST-FAK  fusion  protein, 
which was not phosphorylated on tyrosine residues, bound 
to pp70.  This  tyrosine-phosphorylated  70-kD  protein  was 
also detected  in H9  cells and Jurkat  cells as well as periph- 
eral T  cells by the ligation of 131 integrins  (data not shown). 
In  addition  to  lymphoid  ceils,  pp70  was  also  detected  in 
nonlymphoid  adherent  cell lines  such  as T-47D,  a  human 
Figure 1.  Identification of a tyrosine-phosphorylated 70-kD pp125vAK-associated  protein. (A) HPB-ALL cells were incubated in uncoated (lanes 1-4) 
and FN-coated plates (lanes 5-8). Cellular lysates were precipitated without first Ab (lanes 1 and 5), with 10G2 mAb (lanes 2 and 6), with GST protein 
(lanes 3 and 7), and with GST-FAK fusion protein (lanes 4 and 8) and analyzed by immunoblotting with antipbosphotyrosine mAb (4G10) and the ECL 
system. (B) T-47D cell lysates  were analyzed by the same methods as A using 125I-labeled  4G10 as a probe. Lanes 1-4 in B correspond to lanes 1-4 in A. 
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cubation  of the  GST-FAK  fusion  protein  with  the  10G2 
mAb  essentially  blocked  precipitation  of pp70  (data  not 
shown),  it was conceivable that 10G2 mAb competed with 
pp70 for binding to pp125 FAK. 
To identify the pp70 protein, pp70 was precipitated with 
the GST-FAK fusion protein,  fractionated by SDS-PAGE, 
and  analyzed  by  immunoblotring  with  specific  antibodies 
against candidate  proteins  for pp70.  As shown in Fig.  2  A, 
we found that paxillin was precipitated with GST-FAK fu- 
sion  protein  from  HPB-ALL  cell  lysates  with  or  without 
FN  stimulation,  as  well  as  from  T-47D  cell  lysate,  and  it 
migrated  with  a  mobility  similar  to  pp70,  suggesting  that 
pp70 was identical  to the tyrosine-phosphorylated  paxillin. 
It  was  also  determined  that  tyrosine  phosphorylation  of 
paxillin  was  induced  by  the  ligation  of [31  integrins  in 
HPB-ALL cells  (data not  shown)  and  in peripheral  T  cells 
(27a). To confirm that pp70 was paxillin, pp70 was precip- 
itated by the GST-FAK fusion protein from T-47D cell ly- 
sate,  solubilized  by  boiling  in  buffer  containing  1%  SDS, 
reprecipitated  with  antiphosphotyrosine  mAb or antipaxil- 
lin mAb, and analyzed by immunoblotting with antipaxillin 
mAb (Fig.  2  B)  and with antiphosphotyrosine  mAb (Fig.  2 
C). Tyrosine-phosphorylated pp70, which was precipitated 
with  the  GST-FAK  fusion  protein,  was  detected  by anti- 
paxilhn  mAb  (Fig.  2  B,  lane  4),  and  tyrosine-phosphory- 
lated paxillin  (Fig.  2  C,  lanes  1 and  5)  migrated  with  ex- 
actly the  same mobility as pp70  (Fig.  2  C, lanes  2  and  4). 
Similar results were  obtained  in  FN-stimulated  HPB-ALL 
cells  (data  not  shown).  These  results  confirm  that  pp70  is 
paxillin.  Comparison  of Fig.  2,  B  and  C,  (lanes  2  and  5) 
showed that non-tyrosine-phosphorylated  paxillin was pre- 
cipitated with the GST-FAK fusion protein as well as pp70, 
tyrosine-phosphorylated  paxillin.  Furthermore,  the  paxil- 
lin protein that was precipitated with the GST-FAK fusion 
protein from HPB-ALL cell lysate without  FN stimulation 
was not tyrosine phosphorylated  (Fig.  1 A, lane  4, and Fig. 
2  A,  lane  2).  These  results  strongly  suggest  that  tyrosine 
phosphorylation  of paxillin  is not required  for the binding 
to pp125 FAK. 
Direct Association of  pp 125  FAK with Paxillin.  Although  the 
association  of the  GST-FAK  fusion  protein  with  paxillin 
was demonstrated,  the  following points  remained  unclear: 
(a)  Is endogenous  pp125 FAK associated with paxiUin?  (b)  Is 
paxillin  directly associated with  pp125 F^K or associated in- 
directly via binding  to  other  proteins?  To  define  whether 
endogenous  pp125 F^K protein was associated with paxillin, 
HPB-ALL  and  T-47D  cell  lysates  were  immunoprecipi- 
tated with  antipaxillin  mAb and analyzed by immunoblot- 
ring. As shown in Fig. 3, A  and B, pp125 F^K was coprecip- 
itated  with  paxillin  by  antipaxillin  mAb  (lanes  1-3).  The 
amounts  of coprecipitated  pp125 FAK  appear  to  be  almost 
the same with or without  FN stimulation  (Fig. 3 A, lanes  1 
and  2).  Although  paxillin  was  not  coprecipitated  with 
pp125 F^K by  10G2  mAb  (Fig.  3  B,  lane  4),  it  should  be 
noted  that  paxillin  was  coprecipitated  with  another  anti- 
FAK  mAb  (Transduction  Laboratories,  Lexington,  KY), 
which  recognized  a  different  epitope  of FAK  from  10G2 
rnAb  (data  not  shown).  These  data  further  suggest  that 
10G2  mAb  competes  with  paxillin  for  binding  to 
pp125 F~a~. pp125 FAK was  also  coprecipitated  with  crk,  an 
adapter  protein  composed  of SH2  and  SH3  domains  (28), 
using anti-crk mAb in T-47D cells (Fig.  3 A, lane  5). 
To determine whether the association between pp125 ~AK 
and  paxillin  was  direct  or  indirect,  we  next  performed 
overlay assay using 125I-labeled GST-FAK fusion protein as 
a  probe.  Immunoprecipitated  paxillin  was  analyzed  by 
overlay assay with 125I-labeled GST-FAK fusion protein. As 
shown in Fig. 4 A, a protein of 68 kD was detected by 12sI- 
labeled  GST-FAK  fusion  protein  on  the  lanes  of precipi- 
tates  with  antipaxillin  mAb  (lanes  1  and  2),  whereas  no 
protein  was  detected  using  control  precipitations  (lanes  3 
and  4).  This  protein  had  the  same mobility as paxillin  by 
reprobing of the membrane with  anti-paxillin  mAb (Fig.  4 
Figure 2.  Identification ofpp70 as paxillin. (A) Cellular 
lysates of HPB-ALL cells incubated in uncoated (lanes 1 
and 2) and FN-coated plates (lanes 3 and 4) and T-47D 
cells (lanes 5 and 6) were precipitated with GST protein 
(lanes 1, 3, and 5) or GST-FAK fusion protein (lanes 2, 
4, and 6) and analyzed by imrnunoblotting with antipax- 
illin mAb (Transduction Laboratories) and the ECL sys- 
tem. (B) T-47D cell lysates were precipitated with anti- 
paxillin mAb (lane 1) or with GST-FAK fusion protein 
(lane 2). After precipitation with GST-FAK fusion pro- 
tein, associated  molecules were solubilized and reprecipi- 
tated without first Ab (lane 3), antiphosphotyrosine mAb 
(4G10)-conjugated beads (lane 4),  or antipaxillin mAb 
(lane 5). Precipitates were analyzed by immunoblotting 
with  antipaxillin mAb and the  ECL system. Since five 
times more protein was used for precipitation than in A, 
nonspecific binding of paxillin to beads was observed in 
lane 3. (C) The same membrane used in B was reprobed 
with 125I-labeled  antiphosphotyrosine mAb (4G10). 
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of HPB-ALL  cells incubated in uncoated  (lane  1)  or FN-coated plate 
(lane 2) and T-47D cells (lanes 3-6) were immunoprecipitated  with anti- 
paxillin mAb (lanes I-3),  10G2 mAb (lane 4), anti-crk mAb (Transduc- 
tion Laboratories) (lane 5),  and without first Ab  (lane 6).  Precipitates 
were  analyzed by immunoblotting with anti-FAK mAb (Transduction 
Laboratories) and the ECL system, mAbs used for immunoprecipitation 
were detected at 55 kD. (B) The same membrane used in A was reprobed 
with antipaxiUin Ab and the ECL system. A 125-kD protein in lanes 3 
and 4 is pp125  vAK because of the remaining mAb of A. 
B).  The  above results demonstrate a  direct association be- 
tween pp125 rAK and paxillin. 
Identification of Paxillin-binding  Domain of  pp125  FAK.  To 
determine  the  paxillin-binding domain  of pp125  FAK, we 
developed several deletion mutants derived from the GST- 
FAK fusion protein.  HPB-ALL cell lysates were  incubated 
with these deletion mutant proteins, precipitated, and ana- 
lyzed by immunoblotting with antipaxillin mAb. As shown 
in  Fig.  5  A,  GST  fusion  protein  containing  pp125  rAK 
amino acid residues 706-1052 and 903-1052 retained pax- 
illin-binding activity,  whereas  fusion  proteins  containing 
FAK residues 706-997 and 903-997 did not bind to paxil- 
lin. These results indicate that the paxillin-binding domain 
is  located  in  pp125 FAK residues  903-1052.  To  define  the 
paxillin-binding domain  of pp125 F^K  more  precisely,  we 
developed  additional  deletion  mutants  of the  GST-FAK 
fusion protein by PC1K and performed the paxillin-binding 
assay with  these  mutants.  As  shown  in  Fig.  5  C,  deletion 
mutants  containing  pp125 v^K  residues  896-1047,  896- 
1052, 903-1052,  and 919-1052 precipitated paxillin, while 
mutants  containing  FAK  residues  896-1038,  939-1052, 
903-997,  896-1005,  896-1015,  896-1027,  and 967-1052 
did  not  precipitate  paxillin.  The  amounts  of the  mutant 
proteins used for precipitation are shown in Fig. 5  E. From 
precipitation analysis with deletion mutants shown in Fig. 5 
and  the  additional  mutants  (summarized  in  Table  1),  we 
conclude that pp125  FAK residues 919-1042 are sufficient for 
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Figure 4.  Direct association of paxiUin with pp125 FAK. (A) Cellular ly- 
sates of HPB-ALL cells (lanes 1 and 3) and T-47D cells (lanes 2 and 4) 
were precipitated with antipaxiUin mAb (lanes 1 and 2) or without first 
Ab (lanes 3 and 4). Precipitates were analyzed by overlay assay with 1251- 
labeled GST-FAK fusion protein containing  FAK residues 706-t052 and 
autoradiographed  for 2 d.  (B) The same membrane used in A was re- 
probed with antipaxillin mAb and the ECL system. 
the  association with paxillin. Deletion mutants containing 
FAK  residues  923-1052  or  896-1039  did  not  precipitate 
paxillin,  suggesting  that  the  amino  acid  residues  of 
pp125 r^K,  which  are  critical  for  paxillin binding,  are  lo- 
cated  close  to  both  ends  of the  paxillin-binding domain, 
residues 919-1042. This paxillin-binding  domain of human 
pp125 F^K  overlaps  with  the  FAT  domain  of  chick 
pp125 FAK. Hildebrand et  al.  reported  that  chick pp125  FAK 
Figure 5.  Paxillin binding analysis with deletion  mutants of GST-FAK 
fusion proteins.  (A) HPB-ALL cell lysates were precipitated with GST- 
FAK fusion proteins. Precipitates were analyzed by immunoblotting  with 
antipaxillin mAb and ECL system. (B) The same membrane used in A 
was reprobed  with 125I-labeled 10G2 mAb.  (C)  HPB-ALL  cell lysates 
were precipitated with deletion mutants of GST-FAK fusion proteins and 
analyzed by immunoblotting  with antipaxillin mAb and the ECL system. 
(D) The same membrane used in C was reprobed with 12SI-labeled  10G2 
mAb. (E) The same membrane used in C and D was stained with Pon- 
ceau S (Sigma Chemical Co.). Table  1,  Summary  of the Functions of GST-FAK Fusion Proteins 
Deletion mutants  10G2*  PB*  FATw  Substitution mutants  10G2  PB  FAT 
706-1052  +  +  +  923  K  -+ E  +  +  + 
706-841  -  -  NDII  928  V --+ G  -+  -  - 
706-904  -  -  -  929  T  --+ A  +  +  ND 
706-997  -  -  ND  929  T  --+ S  +  +  ND 
706-1038  +  -  -  931  L --> 1~  __  -  - 
896-1005  --  -  ND  933  K -+ E  +  +  ND 
896-1015  -  -  ND  935  V --+ A  +  -  ND 
896-1027  -  -  ND  1033  N  --+ D  +  +  NI) 
896-1038  +  -  -  1034  L --+ S  +  -  - 
896-1039  +  -  -  1035  L -+ A  +  -  ND 
896-1042  +  +  ND  1036  D  --+ H  +  +  + 
896-1047  +  +  ND  1037  V -+ D  +  -  ND 
896-1052  +  +  +  1039  D  --+ A  +  -  ND 
903-1052  +  +  +  1040  Q  --+ E  +  +  ND 
903-997  -  -  ND  1040  Q  -+ G  +  +  ND 
919-1052  +  +  +  1040  Q  --+ K  +  +  ND 
923-1052  +  -  ND  1042  R. -+ G  +  -  ND 
928-1052  +  -  -  1043  L --+ R.  +  +  + 
939-1052  +  -  - 
967-1052  +  -  ND 
Paxillin-binding activity,  focal adhesion-targeting activity,  and 10G2 mAb-binding activity of each GST-FAK fusion protein are summarized.  Pax- 
illin-binding activity represents the activity to precipitate paxillin from cellular lysates. Focal adhesion-targeting activity was determined by immuno- 
histochemical  analysis of the microinjected fusion protein.  10G2 mAb-binding activity was determined by immunoblotting with 125I-labeled 10G2 
mAb. 
"10G2 mAb-binding activity. 
* Paxillin-binding activity. 
Focal adhesion-targeting activity. 
IlNot determined. 
mutants  with  a  deletion  that  corresponds  to  human 
pp125 FaK  residues  861-967  or  969-1016  resulted  in  the 
loss of FAT (21).  Since these two mutants have deletions in 
the paxillin-binding domain,  these mutants  are expected to 
lack paxillin-binding activity, suggesting the  relevance be- 
tween  paxillin-binding  activity and  FAT of ppl25 FAK. To 
determine  the  10G2  mAb  epitope,  the  same  membranes 
used  in  Fig.  5,  A  and  C,  were  reprobed  with  12SI-labeled 
10G2  mAb.  As shown  in  Fig.  5,  B  and  D,  the  epitope  of 
10G2  mAb  was  mapped  within  pp125 FAK  residues  939- 
1038,  indicating  that  the  epitope  of 10G2  mAb  is located 
within the paxillin-binding domain ofppl25 FAK. 
Identification of  pp 125  yAK Amino Acid Residues Essential for 
PaxiUin Binding.  PaxiUin was first identified as a  vinculin- 
binding protein (23). Vinculin, a  ll6-kD  cytoskeleton pro- 
tein,  is  also  localized  at  focal  adhesions,  and  the  paxillin- 
binding  domain  of vinculin  was  identified  recently  (24). 
Chick vinculin residues 881-1000  are sufficient for paxillin 
binding,  and  vinculin  residues  979-1000  are  critical  for 
paxillin  binding.  Comparison  of paxillin-binding  domains 
between pp125 FAK and vinculin revealed several conserved 
amino  acid residues.  As shown  in  Fig.  6,  two  subdomains 
located  on  both  ends  of the  paxillin-binding  domain  of 
pp125 yAK have homology with the paxillin-binding domain 
of vinculin,  pp125 F^K residues  919-935  and  vinculin  resi- 
dues 952-968  share a sequence,  R/K  X6 E/D  X  V  T  X  L 
X3 V/L  (paxillin-binding subdomain  1  [PBS1]).  pp125 r^K 
residues  1034-1039  and  vinculin  residues  981-986  also 
share a sequence, L  L X  V  X  D/E  (paxillin-binding subdo- 
main  2  [PBS2]).  To  determine  the  role  of these  homolo- 
gous  amino  acid  residues  in  the  interaction  with  paxillin, 
we  generated  substitution  mutants  within  pp125 v^K  resi- 
dues  896-1052  and  performed  paxillin-binding  analysis 
with these mutant proteins.  As shown in Fig. 7 A, substitu- 
tions of either residue 928 Val to Gly, 931  Leu to Arg, and 
935  Val to Ala in PBS1  resulted in a  significant decrease in 
paxillin-binding  activity,  whereas  substitutions  of 923  Lys 
to  Glu,  929  Thr to Ala or Ser,  and 933  Lys to  Glu had no 
effect  on  paxillin  binding.  In  PBS2,  substitutions  of 1034 
Leu to Ser,  1035 Leu to Ala,  1037 Val to Asp,  1039 Glu to 
Ala,  and  1042  Arg to  Gly significantly  decreased  paxillin- 
binding  activity,  whereas  1033  Asn  to  Asp,  1036  Glu  to 
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Figure  6.  Sequence homology between pp125  vtaf and 
vinculin. Amino acid sequences of the paxillin-binding 
domains  of  vincutin  and  ppt25  vmf.  Amino  acid  se- 
quences  of  the  paxiUin-binding  domains  of  human, 
mouse,  and  chick  pp125  Ftai are  conserved.  Conserved 
amino acids between pp125 v^K and vinculin are boxed. 
Substituted FAK residues used in the following analysis 
and paxillin-binding activity of each mutant are shown 
below FAK sequence, 
His,  1040  Gln to Glu,  Gly, or Lys, and  1043  Leu to Arg 
did not. These results clearly indicate that conserved or ho- 
mologous amino acids  between pp125  Fta~ and vinculin are 
essential  for paxillin binding. 
Biological Relevance between the  Paxillin Binding and  the 
FATofpp125  FAK.  Given  that  the  paxillin-binding  do- 
main and the FAT domain ofppl25  Fmr overlap each other, 
one of the putative biological functions of ppl25  ~ta~ bind- 
ing to paxiUin would be the recruitment ofppl25  Fta~ to fo- 
cal adhesions.  To elucidate this possibility, we performed im- 
munohistochemical analysis combined with microinjection 
of GST-FAK fusion proteins.  The GST-FAK fusion pro- 
tein containing FAK residues 706-1052  (GST-FAK 706- 
1052)  was microinjected into 3T3 Swiss albino cells by the 
syringe-loading  method  (27)  and  analyzed  by  immuno- 
staining with anti-GST mAb and FITC-labeled anti-mouse 
IgG Ab. As shown in Fig. 8, C and D, microinjected GST- 
FAK 706-1052 was detected at focal adhesions and local- 
ized at the ends ofactin stress fibers by double staining with 
rhodamine-labeled phailoidine  (Fig.  8  E).  Depending on 
the efficiency ofmicroinjection (shown in Fig.  8 B), GST- 
FAK 706-1052 was not detected in all cells (Fig.  8  C), al- 
though endogenous paxillin was detected at focal adhesions 
in all cells  (Fig.  8 A)  as well as endogenous pp125  F^r~ and 
vinculin  (data  not  shown).  Microinjected  GST  protein, 
which  did  not  contain  a  pp125  r  peptide,  was  not  de- 
tected at focal adhesions (Fig.  8 F). Next, the FAT of the 
deletion mutants  of GST-FAK fusion proteins was  deter- 
mined  by  the  same  method.  GST-FAK  fusion  proteins 
containing  pp125  rta~ residues  896-1052  (Fig.  8  H)  and 
919-1052 (Fig. 8J), which had binding activity to paxillin, 
were localized to  focal adhesions,  whereas  GST-FAK fu- 
sion proteins containing FAK residues 706-904 (Fig.  8  G), 
896--1038  (Fig.  8 /), and 939-1052  (Fig.  8 K), which had 
no binding activity to paxillin, were not localized to focal 
adhesions.  These  results  indicate  that  pp125  F~a~ residues 
919-1052  are sufl]cient for the FAT of FAK.  For further 
study  of  the  role  of  paxillin  binding  in  the  FAT  of 
pp125 ~^K, similar analysis was performed using substitution 
mutants of GST-FAK 896--1052. GST-FAK mutants con- 
taining substitutions of 928 Gly (data not shown), 931  Arg 
(Fig.  8  L), and  1034 Ser (Fig.  8 M]  were not localized to 
focal adhesions, whereas substitution mutants carrying 923 
Glu (data  not shown),  1036 His (Fig.  8 N), and  1043 Arg 
(data  not shown)  were localized to focal adhesions. These 
results,  summarized in Table 1, clearly depict the relevance 
between  paxillin-binding  activity  and  FAT  activity  of 
pp125 F^K, indicating that pp125 Fta~ localizes to focal adhe- 
sions by its direct interaction with paxillin. 
Figure  7.  Paxillin  binding analysis with  substitution mutants of GST- 
FAK  fusion proteins.  (/1) HPI3-ALL cell  lysates were  precipitated  with 
substitution mutants of GST-FAK fusion proteins and analyzed by immu- 
noblotting  with  antipaxillin  mAb  and  the  ECL  system.  (B)  The  same 
membrane used in A was reprobed with 12Sl-labeled  10G2 mAb. (C) The 
same membrane used in A and B was stained with Ponceau S. 
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Discussion 
pp125 FAre colocalizes with 13l integrins at focal adhesions, 
where cells attach to the extracellular matrix (15,  19). The 
complex architecture of cellular focal adhesions depends on 
numerous protein-protein interactions between  focal ad- 
hesion components. However, the mechanisms and cellular 
components regulating various aspects  of signaling induced 
by integrins are unclear. 
Our previous results  indicated that the ligation of 131 in- 
tegrins induces tyrosine phosphorylations of 140-, 110--130-, 
70-,  55--60-,  and 45-kD proteins.  Some of these proteins 
have been identified to be phospholipase  C  7,  PP 125F^K, 
paxillin, pp59  fx~, and pp56  ~ck, and MAP kinase in peripheral 
T  cells  (27a).  Since 131 integrins lack an intrinsic PTK ac- 
tivity,  these  protein  tyrosine  phosphorylations  strongly 
suggest  the  presence  of a  PTK(s),  which  is  functionally 
linked to  131  integrins,  pp125 F^K is a prime  candidate  for 
such PTKs, since FAK is colocalized with 131 integrins at 
focal adhesions  (15).  pp125 F^K is also  tyrosine phosphory- Figure  8.  Inununohistochemical  analysis of microin- 
jected GST-FAK fusion proteins with anti-GST mAb in 
Swiss 3T3  cells. (A) Antipaxillin  mAb staining of Swiss 
3T3  cells with FITC-labeled goat  anti-mouse  IgG  Ab 
(FITC-Gc~MIgG).  Paxillin  (arrows)  is  homogeneously 
stained at focal adhesions. (B) Live staining of FITC-dex- 
tran-injected Swiss 3T3 cells as a microinjection  control. 
Swiss 3T3  cells were  microinjected  10  mg/ml  FlTC- 
dextran  (average MW 40 kD;  Sigma Chemical  Co.) by 
the syringe loading  method.  Cells were incubated  on a 
cover slip and analyzed by fluoronficroscopy without fix- 
ation. Microinjected FITC-dextran was detected (arrows). 
(C and  D)  Anti-GST mAb staining  of Swiss 3T3  cells 
that  were microinjected  with GST-FAK fusion protein 
containing  FAK residues 706-1052.  Swiss 3T3 cells nil- 
croinjected  GST-FAK  fusion  protein  by  the  syringe 
loading method were fixed, stained with anti-GST mAb 
(Santa Cruz Biotechnology,  Santa Cruz,  CA) and FITC- 
GcxMIgG, and  analyzed by fluoromicroscopy.  Microin- 
jected GST-FAK fusion proteins  (arrows) were detected 
at focal adhesions. Because of the relatively high concen- 
tration  of F1TC-GaMIgG,  the nucleus  was  nonspecifi- 
cally stained.  (E)  rhodanfine-labeted  phalloidine  (Sigma 
Chemical Co.) staining of the same cell as D. Actin stress 
fibers are stained. Compared with D, stainings in  D are 
localized at the ends of actin stress fibers. (F) Anti-GST 
mAb staining of Swiss 3T3 cells that were microinjected 
with GST protein.  Microinjected  GST protein  was not 
detected  at specific sites including  focal adhesions.  (G- 
N) Anf-GST mAb staining of Swiss 3T3 cells that were 
nficroinjected  GST-FAK fusion proteins.  Microinjected 
fusion  proteins  contained  FAK  residues  706-904  (G), 
896-1052  (H),  896-1038  (/),  919-1052  03,  and  939- 
1052  (K). Microinjected  substitution  mutants  of FAK- 
GST fusion protein contained substitutions of 931 Leu to 
Arg (L), 1034 Leu to Ser (M), and I036 Glu to His (N). 
Microinjected GST-FAK fusion proteins localized at fo- 
cal adhesions are shown by arrows. Bars, 10 bm~. 
lated  by  the ligation  of [31  integrins  (18,  19),  and  tyrosine- 
phosphorylated  pp125 F^K  is  an  adaptor  of signaling  mole- 
cules  carrying  SH2  domains.  These  signaling  molecules 
include pp59 fyn and  pp60  .....  (29,  30),  csk  (31),  phosphati- 
dylinositol  3-kinase  (32),  GRB2  (33),  and  crk  (34).  Re- 
cruitment of these signaling molecules to pp125 FAK appears 
to  induce  downstream  signals.  For  example,  activation  of 
MAP  kinase by the R.as pathway  is reported to be induced 
by integrin-ligand binding (27a,  33,  35).  These signals sub- 
sequently result in various biological effects induced by the 
ligation  of [31  integrins.  However,  it  is  still  unclear  how 
pp125 FaK  is  linked  to  integrins  and  how  FAK  is  tyrosine 
phosphorylated  by  the  ligation  of [31  integrins.  In  this  re- 
port,  we  have  shown  the  direct  association  of pp125 FAK 
with paxillin,  and we have  demonstrated  a perfect correla- 
tion  between  the  paxillin-binding  ability of pp125 FAK and 
FAT ofppl25 FAK. 
Paxillin was  first identified  as  a  68-kD  vinculin-binding 
protein  localized  to  focal  adhesions  (23).  Paxillin  is  phos- 
phorylated  on both  serine/threonine  and  tyrosine  residues 
(19).  Paxillin has four LIM domains in its COOH-terminal 
region that are flanked by a unique NH2-terrninal region, and 
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tion of paxillin is invariably accompanied by the tyrosine 
phosphorylation of pp125 F^K, suggesting a  close relation- 
ship between pp125 FA~( and paxillin  (19,  36).  Turner and 
Miller recently showed that pp125 F~ was precipitated with 
the GST-paxillin fusion protein (22), although it was not clar- 
ified whether pp125 FAK was directly associated with paxillin 
and whether pp125 r^K was localized to focal adhesions by 
the association with paxillin. We have shown that paxillin 
is  directly associated with  GST fusion protein containing 
pp125 F^K residues 706-1052 by peptide-to-peptide interac- 
tion and that posttranslational  modifications are not involved 
in pp125F^K-paxillin association. Endogenous pp125 F^K is 
also coprecipitated with paxillin, indicating the in vivo as- 
sociation between pp125 F^K and paxillin. The engagement 
ofintegrins and the subsequent tyrosine phosphorylation of 
pp125 r^a and paxillin appear to have no effect on this asso- 
ciation, since the amount of ppl25 FAK coprecipitated with 
paxillin and the amount of ppl25 FAK in the insoluble frac- 
tion  were  not  altered  by  the  ligation  of [31  integrins  in 
HPB-ALL cells  (Fig.  2 A  and our unpublished data).  The 
pp125 r^K residues 919-1042 were determined to be suffi- 
cient  for the  association  of pp125 F^K  with  paxillin.  This 
paxillin-binding domain ofppl25  F^K shares sequence simi- 
larity  with  the  paxillin-binding  domain  of vinculin,  and 
substitutions of conserved amino acids resulted in the loss 
ofpaxillin-binding activity. Most of the essential  amino ac- 
ids  for paxillin binding are leucine and valine, which  are 
amino  acids  with hydrophobic side  chains and which are 
involved in  the  formation of tertiary structures  and/or a 
hydrophobic pocket(s),  pp125 FA~ residue  1039  Glu has  a 
carboxyl group, which is essential for paxillin binding, since 
the substitution of this glutamate residue to alanine resulted 
in a significant decrease ofpaxillin-binding activity. Despite 
lacking homology with vinculin sequence,  1042 Arg also 
appears to be essential  for paxillin binding. These two pax- 
illin  domains of pp125 F^K and vinculin share homologous 
amino acids, although they also have several differences. In 
pp125 F^K, two  paxillin-binding  subdomains  are  separated 
by the insertion of 98-amino  acid sequence, while PBS1 
and -2 are closely located in vinculin. A  putative binding 
site of PI3 kinase 85-kD subunit is located in this insertion 
sequence of pp125 F^K (37),  and the GRB2-binding site of 
pp125 FAK, which included 925 Tyr, is located in the FAK 
PBS1  (33).  These  two  binding  sites  for  PI3  kinase  and 
GRB2 are not located in vinculin PBS1, suggesting a dif- 
ference between pp125 FAK and vinculin in downstream sig- 
nalings. 
The biological relevance between  the  paxillin-binding 
activity and the FAT activity ofppl25  FAK was clearly dem- 
onstrated by the immunohistochemical analysis of the cells 
microinjected  with  GST-FAK  fusion  proteins.  Deletion 
and substitution mutants with paxillin-binding activity are 
localized to focal adhesions, whereas mutants without pax- 
illin-binding  activity are not localized to  focal adhesions. 
These findings indicate that pp125 ~AK is localized to focal 
adhesions by the association with paxillin. Focal adhesions, 
where cells attach to substrata  via integrin-ECM binding, 
are  also  composed  of cytoskeletal proteins  such  as  talin, 
vinculin, paxillin, FP,.NK, and pp125 rAa  (19,  38). Among 
these  proteins,  vinculin,  which  has  a  conserved paxillin- 
binding domain with pp125 FAK, appears to be localized to 
focal adhesions  by the  association with  paxillin  (24),  and 
talin is associated with vinculin (39).  Our findings strongly 
suggest  that pp125 FAK and other proteins  are localized to 
focal adhesions and linked to [31 integrins via the interac- 
tion with paxillin. It remains to be clarified how pp125 F^K 
and paxillin are tyrosine phosphorylated by the ligation of 
[31 integrins.  The interaction with paxillin appears not to 
be sufficient for tyrosine phosphorylation ofppl25  FAK, since 
non-tyrosine-phosphorylated pp125 FA~  is  associated with 
paxillin in HPB-ALL cells without the ligation of [31 inte- 
grins.  On  the  other hand,  the  induction  of pp125  r^K ty- 
rosine phosphorylation is much stronger by the solid-phase 
cross-linking of [31  integrins on plates  than by the  cross- 
linking in liquid phase (our unpublished data).  This finding 
suggests that focal adhesion formation and FAT ofppl25  rAK 
via paxillin play a crucial role in [31 integrin-mediated ty- 
rosine phosphorylation of pp 125 F^K. 
In summary, pp125 F^K is associated with paxillin and lo- 
calized to  focal adhesions  via paxiUin.  [31  integrin-ligand 
ligation  induces  FAT,  and  tyrosine  phosphorylation  of 
pp125 FAK then induces recruitment of signaling molecules 
to  tyrosine-phosphorylated pp125 F^K, which  presumably 
results  in [31 integrin-mediated cell adhesion, cytoskeleton 
organization, and cell proliferation. 
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